Bee Venom Does Not Reduce the Risk for Parkinson's Disease: Epidemiological Study among Beekeepers

Mov Disord. 2022 Jan;37(1):211-213. doi: 10.1002/mds.28820. Epub 2021 Oct 16.

Abstract

Background: Based on the promising results from preclinical studies, bee venom has been investigated as a neuroprotective agent in Parkinson's disease.

Objective: To assess if longstanding exposure to bee venom is associated with decreased risk for Parkinson's disease among beekeepers.

Methods: Questionnaire gathering information about diagnosis of Parkinson's disease and exposure to bee stings was posted to 6500 members of Slovenian beekeepers' organisation.

Results: We received 1298 responses (response rate 20.1%). Twenty beekeepers, all older than 60 years, were diagnosed with Parkinson's disease. The prevalence of Parkinson's disease in beekeepers aged ≥60 years was 3.9%, which is above the reported 0.6-1.3% prevalence of PD in this age group in European population. There was no difference in parameters reflecting bee venom exposure between beekeepers with and without Parkinson's disease.

Conclusions: Continuous exposure to bee venom does not affect neurodegeneration to the extent where it could prevent the expression of Parkinson's disease. © 2021 International Parkinson and Movement Disorder Society.

Keywords: Parkinson's disease; bee venom; beekeepers; neuroprotective effects.

MeSH terms

  • Animals
  • Bee Venoms*
  • Bees
  • Epidemiologic Studies
  • Insect Bites and Stings*
  • Occupational Diseases* / epidemiology
  • Parkinson Disease* / epidemiology

Substances

  • Bee Venoms